ESC Forum on Drug Eluting Stents European Heart House, Nice, 27-28 September 2007.

Authors :: Daemen J
Simoons ML
Wijns W
Bagust A
Bos G
Bowen JM
Braunwald E
Camenzind E
Chevalier B
Dimario C
Fajadet J
Gitt A
Guagliumi G
Hillege HL
James S
Jüni P
Kastrati A
Kloth S
Kristensen SD
Krucoff M
Legrand V
Pfisterer M
Rothman M
Serruys PW
Silber S
Steg PG
Tariah I
Wallentin L
Windecker SW
Aimonetti A
Allocco D
Baczynska A
Bagust A
Berenger M
Bos G
Boam A
Bowen JM
Braunwald E
Calle JP
Camenzind E
Campo G
Carlier S
Chevalier B
Daemen J
de Schepper J
Di Bisceglie G
Dimario C
Dobbels H
Fajadet J
Farb A
Ghislain JC
Gitt A
Guagliumi G
Hellbardt S
Hillege HL
Ten Hoedt R
Isaia C
James S
de Jong P
Jüni P
Kastrati A
Klasen E
Kloth S
Kristensen SD
Krucoff M
Legrand V
Lekehal M
Lenarz L
Ni Mhullain F
Nagai H
Patteet A
Paunovic D
Pfisterer M
Potgieter A
Purdy I
Raveau-Landon C
Rothman M
Serruys PW
Silber S
Simoons ML
Steg PG
Tariah I
Ternstrom S
Van Wuytswinkel J
Waliszewski M
Wallentin L
Wijns W
Windecker SW
Source :: European heart journal [Eur Heart J] 2009 Jan; Vol. 30 (2), pp. 152-61. Date of Electronic Publication: 2008 Nov 26.
Publication Year :: 2009

Subjects :: Coronary Disease mortality
Coronary Disease therapy
Coronary Restenosis prevention & control
Coronary Thrombosis etiology
Coronary Thrombosis mortality
Epidemiologic Methods
France
Humans
Myocardial Infarction mortality
Myocardial Revascularization adverse effects
Myocardial Revascularization standards
Drug-Eluting Stents adverse effects
Drug-Eluting Stents economics
Drug-Eluting Stents standards

Full Text Access

Tools